Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.07 -0.01 (-0.72%)
As of: Oct 22, 2026 · 9:53 AM EDT

Black Diamond Therapeutics (BDTX) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Black Diamond Therapeutics' Depreciation & Amortization (CF) came in at $28,000 for Q2 2026, down 67.4% from $86,000 a year earlier but up 3.7% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Black Diamond Therapeutics reported Depreciation & Amortization (CF) of $207,000, down 39.8% year-over-year; for FY2025, it was $325,000, down 5.2% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, though with a five-year compound annual growth rate of 44.3% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $343,000 in FY2024 (-21.5%), $437,000 in FY2023 (-14.0%), $508,000 in FY2022 (+147.8%) and $205,000 in FY2021 (+294.2%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $27,000 (Q1 2026) to $129,000 (Q3 2022).
  • Year-over-year, Depreciation & Amortization (CF) has declined for three consecutive quarters, with an average decline of 23.0% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 720.0%), and the weakest in Q1 2026 (a decline of 69.0%).
  • Business Quant data shows BDTX's Depreciation & Amortization (CF) at $27,000 (Q1 2026), $66,000 (Q4 2025) and $86,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,160.65 Bn 1,129.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 633.19 Bn 551.72 Bn 17.26 Bn 1.96 Bn
3 AbbVie 501.90 Bn 475.01 Bn 12.70 Bn 194.00 Mn
4 Merck 377.07 Bn 331.45 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.35 Bn 266.34 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.93 Bn
7 Amgen 240.68 Bn 196.07 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 1.62 Bn
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn - 28,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28,000.00
Mar 31, 2026 27,000.00
Dec 31, 2025 66,000.00
Sep 30, 2025 86,000.00
Jun 30, 2025 86,000.00
Mar 31, 2025 87,000.00
Dec 31, 2024 85,000.00
Sep 30, 2024 86,000.00
Jun 30, 2024 86,000.00
Mar 31, 2024 86,000.00
Dec 31, 2023 86,000.00
Sep 30, 2023 115,000.00
Jun 30, 2023 114,000.00
Mar 31, 2023 122,000.00
Dec 31, 2022 126,000.00
Sep 30, 2022 129,000.00
Jun 30, 2022 128,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 123,000.00
Sep 30, 2021 43,000.00
API Access

Black Diamond Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BDTX&period=max&api_key=YOUR_API_KEY